Form D · Biotechnology

VITARA BIOMEDICAL, INC.

Philadelphia, PA · CIK 0001811355

Offering snapshot reported Oct 28, 2024 · SEC filing

Reported sold
$10M
Offering amount: $50M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 11, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 28, 2024Initial$9,999,840No comparison9SEC filing
Dec 6, 2023Amendment$39,996,256$14,998,518vs Aug 2, 20229SEC filing
Aug 1, 2023Amendment$24,997,738$0vs Aug 2, 20229SEC filing
Aug 2, 2022Amendment$24,997,738$0vs Jul 29, 20229SEC filing
Jul 29, 2022Initial$24,997,738No comparison9SEC filing
May 21, 2020Initial$20,000,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-527920

Source: Form D, filed Oct 28, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Arthur Dantchik Director
Ted Fjallman Director
Nelson Hill Director
Jeffrey Kahn Executive
John Kelly Executive
Manish Kothari Director
Monash Kothari Director
Bernard Lyons Director, Executive
James Mc Glone Director, Executive
Diem Nguyen Director
Rosaleen Oskanian Executive
Ian Ratcliffe Director
Thomas Todorow Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2301 Chestnut Street 4th Floor
Philadelphia, PA, 19103